Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 20 | 2025 | 955 | 1.600 |
Why?
|
| Vietnam | 25 | 2025 | 185 | 0.950 |
Why?
|
| Substance Abuse, Intravenous | 5 | 2025 | 83 | 0.870 |
Why?
|
| Methadone | 8 | 2017 | 140 | 0.800 |
Why?
|
| Opiate Substitution Treatment | 8 | 2017 | 223 | 0.710 |
Why?
|
| Sex Workers | 2 | 2025 | 17 | 0.620 |
Why?
|
| AIDS Serodiagnosis | 2 | 2016 | 19 | 0.520 |
Why?
|
| Drug Users | 4 | 2016 | 29 | 0.480 |
Why?
|
| Homosexuality, Male | 4 | 2025 | 29 | 0.480 |
Why?
|
| Anti-HIV Agents | 5 | 2025 | 139 | 0.460 |
Why?
|
| Unsafe Sex | 3 | 2016 | 27 | 0.460 |
Why?
|
| Ketocholesterols | 1 | 2014 | 1 | 0.430 |
Why?
|
| Amyloid | 1 | 2014 | 73 | 0.410 |
Why?
|
| Alcoholism | 4 | 2024 | 327 | 0.380 |
Why?
|
| HIV Seropositivity | 4 | 2017 | 81 | 0.380 |
Why?
|
| Peptide Fragments | 1 | 2014 | 417 | 0.370 |
Why?
|
| Amyloid beta-Peptides | 1 | 2014 | 321 | 0.360 |
Why?
|
| Pre-Exposure Prophylaxis | 2 | 2022 | 15 | 0.360 |
Why?
|
| Attitude to Health | 1 | 2013 | 296 | 0.340 |
Why?
|
| Counseling | 3 | 2025 | 375 | 0.340 |
Why?
|
| Cross-Sectional Studies | 16 | 2022 | 2702 | 0.330 |
Why?
|
| Transgender Persons | 2 | 2022 | 69 | 0.330 |
Why?
|
| Tobacco Use Disorder | 3 | 2017 | 246 | 0.300 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2024 | 767 | 0.280 |
Why?
|
| Drug Monitoring | 3 | 2024 | 202 | 0.270 |
Why?
|
| Adult | 22 | 2025 | 17313 | 0.260 |
Why?
|
| Opioid-Related Disorders | 5 | 2017 | 526 | 0.250 |
Why?
|
| Smoking | 3 | 2017 | 861 | 0.250 |
Why?
|
| Socioeconomic Factors | 6 | 2017 | 801 | 0.250 |
Why?
|
| Ambulatory Care Facilities | 2 | 2025 | 105 | 0.250 |
Why?
|
| Risk-Taking | 5 | 2016 | 159 | 0.230 |
Why?
|
| Condoms | 2 | 2016 | 47 | 0.220 |
Why?
|
| Needle Sharing | 1 | 2015 | 14 | 0.220 |
Why?
|
| Qualitative Research | 3 | 2024 | 745 | 0.220 |
Why?
|
| Sentinel Surveillance | 1 | 2025 | 19 | 0.220 |
Why?
|
| Social Class | 4 | 2017 | 137 | 0.210 |
Why?
|
| Female | 23 | 2025 | 33927 | 0.200 |
Why?
|
| Sexual Behavior | 2 | 2016 | 191 | 0.200 |
Why?
|
| Analgesics, Opioid | 3 | 2017 | 526 | 0.200 |
Why?
|
| Drug Resistance, Viral | 1 | 2025 | 160 | 0.200 |
Why?
|
| Substance-Related Disorders | 5 | 2017 | 750 | 0.190 |
Why?
|
| Male | 22 | 2025 | 30953 | 0.190 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2016 | 496 | 0.190 |
Why?
|
| Motivation | 2 | 2015 | 294 | 0.190 |
Why?
|
| Young Adult | 9 | 2025 | 4793 | 0.190 |
Why?
|
| Humans | 28 | 2025 | 64954 | 0.180 |
Why?
|
| Mobile Applications | 1 | 2023 | 140 | 0.170 |
Why?
|
| HIV-1 | 2 | 2025 | 706 | 0.170 |
Why?
|
| Harm Reduction | 2 | 2015 | 33 | 0.170 |
Why?
|
| Health Personnel | 1 | 2024 | 384 | 0.160 |
Why?
|
| Health Services Accessibility | 2 | 2016 | 592 | 0.160 |
Why?
|
| Smoking Cessation | 2 | 2015 | 551 | 0.160 |
Why?
|
| Adolescent | 8 | 2025 | 6293 | 0.150 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2016 | 94 | 0.150 |
Why?
|
| Sexual and Gender Minorities | 1 | 2021 | 76 | 0.150 |
Why?
|
| Narcotics | 2 | 2016 | 57 | 0.140 |
Why?
|
| Telemedicine | 1 | 2023 | 363 | 0.140 |
Why?
|
| Deductibles and Coinsurance | 1 | 2017 | 9 | 0.130 |
Why?
|
| Prevalence | 5 | 2016 | 1439 | 0.120 |
Why?
|
| Mutation | 1 | 2025 | 2657 | 0.120 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2016 | 129 | 0.120 |
Why?
|
| Educational Status | 2 | 2016 | 278 | 0.120 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2016 | 43 | 0.120 |
Why?
|
| Drug Costs | 1 | 2016 | 55 | 0.120 |
Why?
|
| Social Stigma | 1 | 2016 | 76 | 0.110 |
Why?
|
| Anti-Retroviral Agents | 1 | 2015 | 76 | 0.110 |
Why?
|
| Membrane Fluidity | 1 | 2014 | 15 | 0.110 |
Why?
|
| Health Expenditures | 1 | 2016 | 121 | 0.110 |
Why?
|
| Alcohol Drinking | 3 | 2024 | 322 | 0.110 |
Why?
|
| Jurkat Cells | 1 | 2014 | 109 | 0.110 |
Why?
|
| Membrane Microdomains | 1 | 2014 | 51 | 0.110 |
Why?
|
| Quality of Life | 3 | 2016 | 1255 | 0.100 |
Why?
|
| Liposomes | 1 | 2014 | 116 | 0.100 |
Why?
|
| Middle Aged | 8 | 2025 | 18208 | 0.100 |
Why?
|
| Health Care Costs | 1 | 2016 | 223 | 0.100 |
Why?
|
| Voluntary Programs | 1 | 2013 | 4 | 0.100 |
Why?
|
| Medication Adherence | 3 | 2023 | 199 | 0.100 |
Why?
|
| Health Status | 1 | 2016 | 447 | 0.100 |
Why?
|
| Cholesterol | 1 | 2014 | 261 | 0.100 |
Why?
|
| Protein Transport | 1 | 2014 | 404 | 0.100 |
Why?
|
| Urethral Diseases | 1 | 2012 | 13 | 0.090 |
Why?
|
| Syphilis | 1 | 2012 | 25 | 0.090 |
Why?
|
| Patient Satisfaction | 1 | 2015 | 434 | 0.090 |
Why?
|
| Chlamydia Infections | 1 | 2012 | 79 | 0.090 |
Why?
|
| Healthcare Disparities | 1 | 2016 | 407 | 0.090 |
Why?
|
| Surveys and Questionnaires | 5 | 2017 | 2759 | 0.080 |
Why?
|
| Gonorrhea | 1 | 2012 | 162 | 0.080 |
Why?
|
| Models, Organizational | 2 | 2016 | 91 | 0.060 |
Why?
|
| Health Care Surveys | 2 | 2016 | 288 | 0.060 |
Why?
|
| Law Enforcement | 1 | 2015 | 26 | 0.050 |
Why?
|
| Injections | 1 | 2024 | 84 | 0.050 |
Why?
|
| Self Report | 2 | 2017 | 391 | 0.050 |
Why?
|
| Workload | 1 | 2025 | 130 | 0.050 |
Why?
|
| Organizational Culture | 1 | 2025 | 115 | 0.050 |
Why?
|
| Delayed-Action Preparations | 1 | 2024 | 120 | 0.050 |
Why?
|
| Viral Load | 1 | 2025 | 230 | 0.050 |
Why?
|
| Leadership | 1 | 2025 | 211 | 0.050 |
Why?
|
| Interviews as Topic | 1 | 2015 | 529 | 0.050 |
Why?
|
| Hormones | 1 | 2022 | 62 | 0.050 |
Why?
|
| World Health Organization | 1 | 2022 | 35 | 0.050 |
Why?
|
| Alcohol Abstinence | 1 | 2022 | 13 | 0.050 |
Why?
|
| Naltrexone | 1 | 2022 | 91 | 0.040 |
Why?
|
| Research Design | 1 | 2023 | 585 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 801 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2024 | 625 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2022 | 5776 | 0.040 |
Why?
|
| Financing, Personal | 1 | 2017 | 23 | 0.030 |
Why?
|
| Developing Countries | 1 | 2017 | 87 | 0.030 |
Why?
|
| Vulnerable Populations | 1 | 2017 | 94 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2022 | 721 | 0.030 |
Why?
|
| Health Services Administration | 1 | 2016 | 4 | 0.030 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2016 | 95 | 0.030 |
Why?
|
| Binge Drinking | 1 | 2016 | 38 | 0.030 |
Why?
|
| Health Resources | 1 | 2016 | 92 | 0.030 |
Why?
|
| Risk | 1 | 2016 | 374 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 929 | 0.030 |
Why?
|
| Urban Population | 1 | 2016 | 200 | 0.030 |
Why?
|
| Risk Factors | 2 | 2016 | 5408 | 0.030 |
Why?
|
| Logistic Models | 1 | 2017 | 1270 | 0.030 |
Why?
|
| Rural Population | 1 | 2016 | 223 | 0.030 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2015 | 142 | 0.020 |
Why?
|
| Poverty | 1 | 2015 | 304 | 0.020 |
Why?
|
| Social Support | 1 | 2015 | 391 | 0.020 |
Why?
|
| Comorbidity | 1 | 2015 | 1113 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 432 | 0.020 |
Why?
|
| Depression | 1 | 2015 | 899 | 0.020 |
Why?
|